TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T64591	5-HT 3A receptor	D01HVZ	TD-8954	Phase 1/2	11961293	C25H37N5O3	455.6	CC(C)C1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CC4CCN(CC4)C(=O)OC	Ki = 100000 nM	Poor binder
T64591	5-HT 3A receptor	B19JPN	5-[2-(1-Benzofuran-5-yl)ethynyl]-1-methyl-3-(piperidin-1-ylmethyl)pyrrolidin-2-one	Investigative	11660066; 44157061	C21H24N2O2	336.4	CN1C(CC(C1=O)CN2CCCCC2)C#CC3=CC4=C(C=C3)OC=C4	IC50 = 100000 nM	Poor binder
T64591	5-HT 3A receptor	B26CVM	4-Methoxy-N-(2,4,6-trimethylphenyl)benzenesulfonamide	Investigative	743974	C16H19NO3S	305.4	CC1=CC(=C(C(=C1)C)NS(=O)(=O)C2=CC=C(C=C2)OC)C	EC50 ~ 50118.72 nM	Poor binder
T64591	5-HT 3A receptor	B2LQZ9	N-[[1-[2-Hydroxy-3-(4-methylsulfonylpiperazin-1-yl)propyl]piperidin-4-yl]methyl]-1H-benzimidazole-4-carboxamide	Investigative	71712611	C22H34N6O4S	478.6	CS(=O)(=O)N1CCN(CC1)CC(CN2CCC(CC2)CNC(=O)C3=C4C(=CC=C3)NC=N4)O	Ki = 50118.72 nM	Poor binder
T64591	5-HT 3A receptor	B3Q8WZ	2-Cyclopropyl-N-[[1-[2-hydroxy-3-(4-methylsulfonylpiperazin-1-yl)propyl]piperidin-4-yl]methyl]-1H-benzimidazole-4-carboxamide	Investigative	71714542	C25H38N6O4S	518.7	CS(=O)(=O)N1CCN(CC1)CC(CN2CCC(CC2)CNC(=O)C3=C4C(=CC=C3)NC(=N4)C5CC5)O	Ki = 50118.72 nM	Poor binder
T64591	5-HT 3A receptor	B41KYB	2-[(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-31-(2-Acetyloxyethyl)-24-phenyl-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaen-15-yl]ethyl acetate;dibromide	Investigative	44427862	C46H56Br2N4O6	920.8	CC(=O)OCC[N+]12CC[C@H]3[C@@H]1C[C@@H]4[C@@H]5[C@@H]3N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N([C@@H]5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CCOC(=O)C)C1=CC=CC=C1.[Br-].[Br-]	Ki ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	B57UBC	CID 72710014	Investigative	72710014	C16H19ClN6O	346.81	C1CN2CCC1C3(C2)CCN=C(O3)NC4=NC=NN5C4=CC=C5Cl	IC50 = 61000 nM	Poor binder
T64591	5-HT 3A receptor	B5EW4F	Methyl (1S,2R,7R,9S,10S,12S,19S)-12-ethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadecane-10-carboxylate;dihydrochloride	Investigative	90664904	C21H36Cl2N2O2	419.4	CC[C@@]12CCCN3[C@@H]1[C@@]4(CC3)[C@H]5CCCC[C@H]5N[C@H]4[C@H](C2)C(=O)OC.Cl.Cl	IC50 ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	B5I2UR	2-Isopropyl-1H-benzoimidazole-4-carboxylic acid [1-(1-methanesulfonylpiperidin-4-ylmethyl)piperidin-4-ylmethyl]amide	Investigative	66810955	C24H37N5O3S	475.6	CC(C)C1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CC4CCN(CC4)S(=O)(=O)C	Ki = 100000 nM	Poor binder
T64591	5-HT 3A receptor	B6DS0X	[20-[[Dimethyl-[(4-nitrophenyl)methyl]azaniumyl]methyl]-3,13-diazapentacyclo[11.7.0.03,11.04,9.014,19]icosa-1(20),4,6,8,10,14,16,18-octaen-10-yl]methyl-dimethyl-[(4-nitrophenyl)methyl]azanium;dibromide	Investigative	17758335	C38H40Br2N6O4	804.6	C[N+](C)(CC1=CC=C(C=C1)[N+](=O)[O-])CC2=C3CN4C(=C(C5=CC=CC=C54)C[N+](C)(C)CC6=CC=C(C=C6)[N+](=O)[O-])CN3C7=CC=CC=C72.[Br-].[Br-]	Ki ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	B6J2OX	N-[[1-[2-Hydroxy-3-(4-methylsulfonylpiperazin-1-yl)propyl]piperidin-4-yl]methyl]-2-propan-2-yl-1H-benzimidazole-4-carboxamide	Investigative	71714541	C25H40N6O4S	520.7	CC(C)C1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CC(CN4CCN(CC4)S(=O)(=O)C)O	Ki = 79432.82 nM	Poor binder
T64591	5-HT 3A receptor	B6MW1Z	Sodium;(1S,2R,7R,9S,10S,12S,19S)-12-ethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadecane-10-carboxylate	Investigative	44559406	C20H31N2NaO2	354.5	CC[C@@]12CCCN3[C@@H]1[C@@]4(CC3)[C@H]5CCCC[C@H]5N[C@H]4[C@H](C2)C(=O)[O-].[Na+]	IC50 ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	B6SQI9	1-Benzo[1,3]dioxol-5-yl-4-[4-(3-methoxy-benzyl)-piperazin-1-yl]-cyclohexanol	Investigative	9845261	C25H32N2O4	424.5	COC1=CC=CC(=C1)CN2CCN(CC2)C3CCC(CC3)(C4=CC5=C(C=C4)OCO5)O	IC50 ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	B83ZEL	N-Pyridin-4-ylspiro[1-azabicyclo[2.2.2]octane-3,5'-4H-1,3-oxazole]-2'-amine	Investigative	76663424	C14H18N4O	258.32	C1CN2CCC1C3(C2)CN=C(O3)NC4=CC=NC=C4	IC50 = 58000 nM	Poor binder
T64591	5-HT 3A receptor	B9M1IH	(3R)-N-(7-Methylpyrrolo[2,1-f][1,2,4]triazin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4H-1,3-oxazole]-2'-amine	Investigative	58081849	C16H20N6O	312.37	CC1=CC=C2N1N=CN=C2NC3=NC[C@]4(O3)CN5CCC4CC5	IC50 = 71000 nM	Poor binder
T64591	5-HT 3A receptor	BA16WL	N-[[1-[2-Hydroxy-3-[methyl(methylsulfonyl)amino]propyl]piperidin-4-yl]methyl]-2-propan-2-yl-1H-benzimidazole-4-carboxamide	Investigative	71712463	C22H35N5O4S	465.6	CC(C)C1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CC(CN(C)S(=O)(=O)C)O	Ki = 79432.82 nM	Poor binder
T64591	5-HT 3A receptor	BA20PH	(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-15,31-Dibenzyl-24-phenyl-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaene;dibromide	Investigative	44427866	C52H56Br2N4O2	928.8	C1C[N+]2(CC3=CCO[C@@H]4[C@@H]5[C@H]3C[C@H]2[C@H]1[C@H]5N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N4C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC1=CC=CC=C1)C1=CC=CC=C1)CC1=CC=CC=C1.[Br-].[Br-]	IC50 = 100000 nM	Poor binder
T64591	5-HT 3A receptor	BA34KF	CID 72709767	Investigative	72709767	C18H22N4O2S	358.5	COC1=CC2=C(C=C1)N=C(S2)NC3=NCCC4(O3)CN5CCC4CC5	IC50 = 64000 nM	Poor binder
T64591	5-HT 3A receptor	BBIF97	(3S)-N-(7-Chloropyrrolo[2,1-f][1,2,4]triazin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4H-1,3-oxazole]-2'-amine	Investigative	134139949	C15H17ClN6O	332.79	C1CN2CCC1[C@]3(C2)CN=C(O3)NC4=NC=NN5C4=CC=C5Cl	IC50 = 87000 nM	Poor binder
T64591	5-HT 3A receptor	BBU2T8	N-[[1-[2-(4-Methylsulfonylpiperazin-1-yl)ethyl]piperidin-4-yl]methyl]-2-propan-2-yl-1H-benzimidazole-4-carboxamide	Investigative	71712327	C24H38N6O3S	490.7	CC(C)C1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CCN4CCN(CC4)S(=O)(=O)C	Ki = 100000 nM	Poor binder
T64591	5-HT 3A receptor	BDTG17	(3R)-N-(5-Phenylpyrazin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4H-1,3-oxazole]-2'-amine	Investigative	137654242	C19H21N5O	335.4	C1CN2CCC1[C@@]3(C2)CN=C(O3)NC4=NC=C(N=C4)C5=CC=CC=C5	IC50 ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	BE1W2K	Trimethyl-[[20-[(trimethylazaniumyl)methyl]-3,13-diazapentacyclo[11.7.0.03,11.04,9.014,19]icosa-1(20),4,6,8,10,14,16,18-octaen-10-yl]methyl]azanium;diiodide	Investigative	44408895	C26H34I2N4	656.4	C[N+](C)(C)CC1=C2CN3C(=C(C4=CC=CC=C43)C[N+](C)(C)C)CN2C5=CC=CC=C51.[I-].[I-]	Ki ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	BE1ZN7	1-[20-[(Dimethylamino)methyl]-3,13-diazapentacyclo[11.7.0.03,11.04,9.014,19]icosa-1(20),4,6,8,10,14,16,18-octaen-10-yl]-N,N-dimethylmethanamine	Investigative	44408892	C24H28N4	372.5	CN(C)CC1=C2CN3C(=C(C4=CC=CC=C43)CN(C)C)CN2C5=CC=CC=C51	Ki ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	BFR30K	3-(4-Fluorophenyl)-N-(2-morpholinoethyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide	Investigative	44422208	C21H21FN4O4	412.4	C1COCCN1CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)C4=CC=C(C=C4)F	IC50 = 57000 nM	Poor binder
T64591	5-HT 3A receptor	BIT3A1	(2E)-2-[(1S,9Z,11S,13S,17R,18R,20R,27S,29R,30R,31S)-14,26-Bis[(3,4-dimethoxyphenyl)methyl]-19-phenyl-21-oxa-8,19-diaza-14,26-diazoniadecacyclo[24.5.2.211,14.01,27.02,7.08,31.010,18.013,17.020,30.024,29]pentatriaconta-2,4,6,9,23-pentaen-35-ylidene]ethanol;dichloride	Investigative	44427881	C56H64Cl2N4O6	960	COC1=C(C=C(C=C1)C[N+]23CC[C@H]4[C@@H]2C[C@@H](/C(=C\\CO)/C3)/C/5=C/N6[C@H]7[C@H]8[C@H]9C[C@H]1[C@@]7(CC[N+]1(CC9=CCO[C@H]8N([C@H]45)C1=CC=CC=C1)CC1=CC(=C(C=C1)OC)OC)C1=CC=CC=C16)OC.[Cl-].[Cl-]	Ki = 100000 nM	Poor binder
T64591	5-HT 3A receptor	BK2E1J	[20-[[Dimethyl(prop-2-enyl)azaniumyl]methyl]-3,13-diazapentacyclo[11.7.0.03,11.04,9.014,19]icosa-1(20),4,6,8,10,14,16,18-octaen-10-yl]methyl-dimethyl-prop-2-enylazanium;dibromide	Investigative	44408940	C30H38Br2N4	614.5	C[N+](C)(CC=C)CC1=C2CN3C(=C(C4=CC=CC=C43)C[N+](C)(C)CC=C)CN2C5=CC=CC=C51.[Br-].[Br-]	Ki ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	BK9WI5	Methyl N-[2-hydroxy-3-[4-[[(2-propan-2-yl-1H-benzimidazole-4-carbonyl)amino]methyl]piperidin-1-yl]propyl]-N-methylcarbamate	Investigative	71712464	C23H35N5O4	445.6	CC(C)C1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CC(CN(C)C(=O)OC)O	Ki = 50118.72 nM	Poor binder
T64591	5-HT 3A receptor	BMQS34	(3R)-N-(7-Methylpyrrolo[2,3-d]pyrimidin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4H-1,3-oxazole]-2'-amine	Investigative	134136620	C16H20N6O	312.37	CN1C=CC2=C(N=CN=C21)NC3=NC[C@]4(O3)CN5CCC4CC5	IC50 = 86000 nM	Poor binder
T64591	5-HT 3A receptor	BNM01B	N-[1-[2-Hydroxy-3-(4-methylsulfonylpiperazin-1-yl)propyl]piperidin-4-yl]-1H-benzimidazole-4-carboxamide	Investigative	71712613	C21H32N6O4S	464.6	CS(=O)(=O)N1CCN(CC1)CC(CN2CCC(CC2)NC(=O)C3=C4C(=CC=C3)NC=N4)O	Ki = 63095.73 nM	Poor binder
T64591	5-HT 3A receptor	BO0Q2D	Methyl 4-[2-[4-[[(2-propan-2-yl-1H-benzimidazole-4-carbonyl)amino]methyl]piperidin-1-yl]ethyl]piperazine-1-carboxylate	Investigative	71712328	C25H38N6O3	470.6	CC(C)C1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CCN4CCN(CC4)C(=O)OC	Ki = 79432.82 nM	Poor binder
T64591	5-HT 3A receptor	BO1VX8	CID 90022612	Investigative	90022612	C18H22N4O2S	358.5	CN\\1CC2(CN3CCC2CC3)O/C1=N/C4=NC5=C(S4)C=C(C=C5)OC	IC50 ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	BOHE83	(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-15,31-Bis[(4-nitrophenyl)methyl]-24-phenyl-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaene;dibromide	Investigative	44427872	C52H54Br2N6O6	1018.8	C1C[N+]2(CC3=CCO[C@@H]4[C@@H]5[C@H]3C[C@H]2[C@H]1[C@H]5N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N4C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC1=CC=C(C=C1)[N+](=O)[O-])C1=CC=CC=C1)CC1=CC=C(C=C1)[N+](=O)[O-].[Br-].[Br-]	IC50 ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	BP34MY	N-[[1-[3-[Acetyl(methyl)amino]-2-hydroxypropyl]piperidin-4-yl]methyl]-2-propan-2-yl-1H-benzimidazole-4-carboxamide	Investigative	71712465	C23H35N5O3	429.6	CC(C)C1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CC(CN(C)C(=O)C)O	Ki = 63095.73 nM	Poor binder
T64591	5-HT 3A receptor	BQ3K4G	N-[[1-[(1-Acetylpiperidin-4-yl)methyl]piperidin-4-yl]methyl]-2-propan-2-yl-1H-benzimidazole-4-carboxamide	Investigative	71712466	C25H37N5O2	439.6	CC(C)C1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CC4CCN(CC4)C(=O)C	Ki = 100000 nM	Poor binder
T64591	5-HT 3A receptor	BQG2Z4	(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-24-Phenyl-15,31-bis(prop-2-enyl)-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaene;dibromide	Investigative	44427858	C44H52Br2N4O2	828.7	C=CC[N+]12CC[C@H]3[C@@H]1C[C@@H]4[C@@H]5[C@@H]3N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N([C@@H]5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC=C)C1=CC=CC=C1.[Br-].[Br-]	Ki = 100000 nM	Poor binder
T64591	5-HT 3A receptor	BS34NT	(2E)-2-[(9Z,11S,13S,17S,25Z,27S,33S,35S,36S,38E)-38-(2-Hydroxyethylidene)-14,30-dimethyl-8,24-diaza-14,30-diazoniaundecacyclo[25.5.2.211,14.11,26.110,17.02,7.013,17.018,23.030,33.08,35.024,36]octatriaconta-2,4,6,9,18,20,22,25-octaen-28-ylidene]ethanol;dichloride	Investigative	44427885	C40H46Cl2N4O2	685.7	C[N+]12CC[C@@]34[C@@H]1C[C@@H](/C(=C\\CO)/C2)/C/5=C/N6[C@H]7/C(=C\\N([C@@H]53)C8=CC=CC=C48)/[C@H]\\9C[C@H]1C7(CC[N+]1(C/C9=C/CO)C)C1=CC=CC=C16.[Cl-].[Cl-]	IC50 ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	BTSP48	(3S)-N-(6-Methoxy-1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4H-1,3-oxazole]-2'-amine	Investigative	134154585	C17H20N4O2S	344.4	COC1=CC2=C(C=C1)N=C(S2)NC3=NC[C@@]4(O3)CN5CCC4CC5	IC50 ~ 97000 nM	Poor binder
T64591	5-HT 3A receptor	BW2SH0	(2E)-2-[(1S,9Z,11S,13S,14R,17S,25Z,27S,33S,35S,36S,38E)-38-(2-Hydroxyethylidene)-14,30-bis(prop-2-enyl)-8,24-diaza-14,30-diazoniaundecacyclo[25.5.2.211,14.11,26.110,17.02,7.013,17.018,23.030,33.08,35.024,36]octatriaconta-2,4,6,9,18,20,22,25-octaen-28-ylidene]ethanol	Investigative	90659973	C44H50N4O2+2	666.9	C=CC[N@@+]12CC[C@@]34[C@@H]1C[C@@H](/C(=C\\CO)/C2)/C/5=C/N6[C@H]7/C(=C\\N([C@@H]53)C8=CC=CC=C48)/[C@H]\\9C[C@H]1[C@@]7(CC[N+]1(C/C9=C/CO)CC=C)C1=CC=CC=C16	Ki ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	BW9LK2	(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-15,31-Bis[(E)-but-2-enyl]-24-phenyl-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaene;dibromide	Investigative	44427860	C46H56Br2N4O2	856.8	C/C=C/C[N+]12CC[C@H]3[C@@H]1C[C@@H]4[C@@H]5[C@@H]3N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N([C@@H]5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)C/C=C/C)C1=CC=CC=C1.[Br-].[Br-]	IC50 = 100000 nM	Poor binder
T64591	5-HT 3A receptor	BX5US9	CID 72709190	Investigative	72709190	C14H20N6O	288.35	COC1=NC=NC(=C1)NC2=NCC3(N2)CN4CCC3CC4	IC50 ~ 100000 nM	Poor binder
T64591	5-HT 3A receptor	BXPA51	(3R,5S)-5-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethynyl]-1-methyl-3-(piperidin-1-ylmethyl)pyrrolidin-2-one	Investigative	44564663; 56677337	C21H26N2O2	338.4	CN1[C@@H](C[C@@H](C1=O)CN2CCCCC2)C#CC3=CC4=C(C=C3)OCC4	IC50 = 50118.72 nM	Poor binder
T64591	5-HT 3A receptor	BZ8T1U	2-Ethyl-N-[[1-[2-hydroxy-3-(4-methylsulfonylpiperazin-1-yl)propyl]piperidin-4-yl]methyl]-1H-benzimidazole-4-carboxamide	Investigative	71714540	C24H38N6O4S	506.7	CCC1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CC(CN4CCN(CC4)S(=O)(=O)C)O	Ki = 79432.82 nM	Poor binder
T64591	5-HT 3A receptor	BZL54E	(2E)-2-[(1S,9Z,11S,13S,18R,20R,27S,29R,30R,31S)-14,26-Bis[(4-nitrophenyl)methyl]-19-phenyl-21-oxa-8,19-diaza-14,26-diazoniadecacyclo[24.5.2.211,14.01,27.02,7.08,31.010,18.013,17.020,30.024,29]pentatriaconta-2,4,6,9,23-pentaen-35-ylidene]ethanol;dibromide	Investigative	44427883	C52H54Br2N6O6	1018.8	C1C[N+]2(C/C(=C/CO)/[C@@H]\\3C[C@H]2C1[C@@H]4/C3=C\\N5[C@H]6[C@H]7[C@H]8C[C@H]9[C@@]6(CC[N+]9(CC8=CCO[C@H]7N4C1=CC=CC=C1)CC1=CC=C(C=C1)[N+](=O)[O-])C1=CC=CC=C15)CC1=CC=C(C=C1)[N+](=O)[O-].[Br-].[Br-]	Ki = 100000 nM	Poor binder
T64591	5-HT 3A receptor	D0X5DC	linalool	Investigative	6549	C10H18O	154.25	CC(=CCCC(C)(C=C)O)C	IC50 = 141253.75 nM	Poor binder